Skip to main content
. 2019 Jul 31;110(9):2711–2721. doi: 10.1111/cas.14128

Figure 5.

Figure 5

Anti‐programmed death ligand 1 (PD‐L1) and anti‐programmed death ligand 2 (PD‐L2) expression in cancer cells. A, PD‐L1 and PD‐L2 expression was evaluated in 231 patients. B, Patients were divided into four groups based on PD‐L1 and PD‐L2 expression and Kaplan‐Meier analysis was performed